Three Med Device Companies Go Public This Week
January 31, 2015
By Andrew Hoglund

This was a good week for the medical device world as three companies have gone public. The medical device companies that went public were Entellus Medical, Presbia, and Avinger. Entellus Medical and Avinger have done well so far, but Presbia is having a bit of a rough time. Entellus Medical focuses on providing solutions for the minimally invasive treatment of chronic and recurrent sinusitis patients. Their IPO priced at $17, the top of its proposed range, and they sold 4.6 million shares to raise $78 million. Then to top it

Read More

Companies Announce Future Plans, Partnerships, and Financing Deals at J.P. Morgan Conference in San Francisco
January 17, 2015
By Andrew Hoglund

The J.P. Morgan 33rd Annual Healthcare Conference held in San Francisco this past week is a huge conference for medical device companies. It’s a conference that nearly all the major healthcare companies attend and is a great place for companies to show off new products, talk about what they are planning for the future, and announce new partnerships. This is one of the biggest medical device conferences of the year. Oracle, not normally known for being involved in medical device, announced that it will use Proteus’ digital pill in its

Read More

Six Companies Received Millions In Funding This Week
January 10, 2015
By Andrew Hoglund

Several companies raised millions of dollars to help either further develop or market their products this week. Cerus, CardioFocus, 23andMe, PureTech, GlySens, and Sera Prognostics all received funding, either through Series funding, through deals with other companies, or through fund raising of their own. Cerus is in the process of raising $70 million through a public offering of 12.7 million shares at $5.50 a share. Cerus’s stock has jumped in the last couple weeks because of several FDA approvals for their Intercept Blood System to treat blood products. The system

Read More